ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $349,000 | +44.8% | 2,029 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $241,000 | -71.8% | 1,924 | -69.5% | 0.00% | -75.0% |
| Q1 2021 | $854,000 | +3.8% | 6,299 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $823,000 | +13.7% | 6,431 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | +17.3% | 6,431 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $617,000 | +52.3% | 6,479 | +43.8% | 0.00% | +33.3% |
| Q1 2020 | $405,000 | +84.1% | 4,506 | -46.0% | 0.00% | -50.0% |
| Q1 2016 | $220,000 | -41.2% | 8,350 | +8.8% | 0.01% | -40.0% |
| Q4 2015 | $374,000 | +47.8% | 7,673 | -24.4% | 0.01% | +42.9% |
| Q3 2015 | $253,000 | -99.9% | 10,150 | +13.4% | 0.01% | +16.7% |
| Q2 2015 | $283,178,000 | +110950.2% | 8,950 | +33.5% | 0.01% | +20.0% |
| Q1 2015 | $255,000 | – | 6,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |